content

OBI Pharma to develop OBI-3424 (previously TH-3424) as a potential treatment of cancers expressing AKR1C3

OBI Pharma, Inc., a Taiwan biopharma company announced an agreement with Threshold Pharmaceuticals, Inc. to acquire TH-3424, a first-in-class novel small-molecule prodrug that selectively...

AcelRx Pharmaceuticals ZALVISO Recognized for Innovative Design with Prestigious Red Dot Award

AcelRx Pharmaceuticals, Inc , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain....

HedgePath Pharma Announces granting of Type-C meeting request by FDA and provides positive clinical trial update

HedgePath Pharmaceuticals, Inc , a clinical stage biopharmaceutical company that discovers,ย develops and plans to commercialize innovative therapeutics for patients with cancer. ...

Acasti Pharma and CordenPharma Announce Large Scale Production of CaPrewith New Manufacturing Process

Acasti Pharma Inc announcedย the achievement of a major corporate milestone by manufacturing the first cGMP batches of CaPreยฎ, Acastiโ€™sย omega-3 pharmaceutical product candidate, produced with...

West to Present on Biologics Trends at InnoPack Pharma Confex ย 

West Pharmaceutical Services, Inc. , a global leader in innovative solutions for injectable drug administration, today announced that it will deliver a presentation on...

Healthcare Industry Springs to Life at the World’s Largest Healthcare Event – The Health Industry Summit (tHIS)

The Health Industry Summit (tHIS) 2017 hosted by China and organized by Reed Sinopharm, opened in Shanghai at the National Exhibition and Convention Center...

TrialScope Launches Second Global Clinical Trial Disclosure Maturity Assessmentย 

TrialScope, the global leader in clinical trial transparency and compliance solutions announced the release of its second Clinical Trial Disclosure Maturity Survey for clinical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read